Concepedia

Publication | Closed Access

Cardiovascular Outcomes in Type 2 Diabetes: A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study

DOI

273

Citations

0

References

1998

Year

R. S. Elkeles, Judith R Diamond, Clare Poulter, Surinder Dhanjil, Andrew Nicolaides, Shahid Mahmood, W. Richmond, Hugh M Mather, Patrick Sharp, Michael Feher
Diabetes Care

Abstract

Improving dyslipidemia in type 2 diabetic subjects had no effect on the progress of ultrasonically measured arterial disease, although the lower rate of "definite CHD events" in the treated group suggests that this might result in a reduction in the incidence of coronary heart disease.